Cargando…

LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation

BACKGROUND: The active form of vitamin D (1,25 OH2 vitamin D) is catabolized by a key enzyme 1,25 OH vitamin D-24 hydroxylase, which is encoded by the CYP24A1 gene. Loss of function mutation in the CYP24A1 leads to elevated levels of active vitamin D, causing PTH independent hypercalcemia with nephr...

Descripción completa

Detalles Bibliográficos
Autores principales: Agu, Chinyere, Cho, Ei, Resta, Christine, Luba, Rakhlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624935/
http://dx.doi.org/10.1210/jendso/bvac150.303
_version_ 1784822359895572480
author Agu, Chinyere
Cho, Ei
Resta, Christine
Luba, Rakhlin
author_facet Agu, Chinyere
Cho, Ei
Resta, Christine
Luba, Rakhlin
author_sort Agu, Chinyere
collection PubMed
description BACKGROUND: The active form of vitamin D (1,25 OH2 vitamin D) is catabolized by a key enzyme 1,25 OH vitamin D-24 hydroxylase, which is encoded by the CYP24A1 gene. Loss of function mutation in the CYP24A1 leads to elevated levels of active vitamin D, causing PTH independent hypercalcemia with nephrolithiasis and nephrocalcinosis. Two phenotypic variants have been identified: idiopathic infantile hypercalcemia, which is a more severe form presenting in infancy, and a milder form with onset in adulthood as is this case. Pregnancy is known to initiate or worsen the hypercalcemia. CLINICAL CASE: A 27-year-old woman presented at 11 weeks gestation with hyperemesis, noted to have hypercalcemia calcium 15.7mg/dl (8.2 to 10.1 pg/ml), low PTH 2pg/ml (24 -85 pg/ml) with high serum 1,25 OHD 309pg/ml (nl 19.9-79.3 pg/ml). She had low PTHrp, normal ACE level, and negative TB testing. Pre-pregnancy calcium was normal (9.8mg/dl). She had a history of hypercalcemia in previous pregnancy (Calcium 13mg/dl) that ended in IUFD. Family history revealed nephrolithiasis in her sister, mother, and paternal aunt as well as a consanguineous marriage in our patient and her parents. Vitamin D metabolites evaluated via liquid chromatography showed low serum 24,25(OH)2D (0.29ng/ml nl N/A) and elevated 25OHD 138 ng/mL (20-80 ng/ml). Ratio of 25 (OH) Vit D to 24,25(OH)2D was 475.86 (values >80 indicate probable bi-allelic CYP24A1 deletion or mutation. Genetic test pending. CONCLUSION: This case highlights the fact that patients with 24 hydroxylase deficiency may be normocalcemic with hypercalcemia unveiled during pregnancy due to increased 1alpha hydroxylase production by the placenta and kidneys as well as intake of prenatal vitamins containing calciferol. An index of suspicion for CYP24A1 mutation is needed in patients with high active vitamin D metabolites, high or normal calcium, low PTH, family history of kidney stones or worsening hypercalcemia in pregnancy. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m.
format Online
Article
Text
id pubmed-9624935
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96249352022-11-14 LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation Agu, Chinyere Cho, Ei Resta, Christine Luba, Rakhlin J Endocr Soc Bone & Mineral Metabolism BACKGROUND: The active form of vitamin D (1,25 OH2 vitamin D) is catabolized by a key enzyme 1,25 OH vitamin D-24 hydroxylase, which is encoded by the CYP24A1 gene. Loss of function mutation in the CYP24A1 leads to elevated levels of active vitamin D, causing PTH independent hypercalcemia with nephrolithiasis and nephrocalcinosis. Two phenotypic variants have been identified: idiopathic infantile hypercalcemia, which is a more severe form presenting in infancy, and a milder form with onset in adulthood as is this case. Pregnancy is known to initiate or worsen the hypercalcemia. CLINICAL CASE: A 27-year-old woman presented at 11 weeks gestation with hyperemesis, noted to have hypercalcemia calcium 15.7mg/dl (8.2 to 10.1 pg/ml), low PTH 2pg/ml (24 -85 pg/ml) with high serum 1,25 OHD 309pg/ml (nl 19.9-79.3 pg/ml). She had low PTHrp, normal ACE level, and negative TB testing. Pre-pregnancy calcium was normal (9.8mg/dl). She had a history of hypercalcemia in previous pregnancy (Calcium 13mg/dl) that ended in IUFD. Family history revealed nephrolithiasis in her sister, mother, and paternal aunt as well as a consanguineous marriage in our patient and her parents. Vitamin D metabolites evaluated via liquid chromatography showed low serum 24,25(OH)2D (0.29ng/ml nl N/A) and elevated 25OHD 138 ng/mL (20-80 ng/ml). Ratio of 25 (OH) Vit D to 24,25(OH)2D was 475.86 (values >80 indicate probable bi-allelic CYP24A1 deletion or mutation. Genetic test pending. CONCLUSION: This case highlights the fact that patients with 24 hydroxylase deficiency may be normocalcemic with hypercalcemia unveiled during pregnancy due to increased 1alpha hydroxylase production by the placenta and kidneys as well as intake of prenatal vitamins containing calciferol. An index of suspicion for CYP24A1 mutation is needed in patients with high active vitamin D metabolites, high or normal calcium, low PTH, family history of kidney stones or worsening hypercalcemia in pregnancy. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9624935/ http://dx.doi.org/10.1210/jendso/bvac150.303 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Bone & Mineral Metabolism
Agu, Chinyere
Cho, Ei
Resta, Christine
Luba, Rakhlin
LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
title LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
title_full LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
title_fullStr LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
title_full_unstemmed LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
title_short LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
title_sort lbsat130 hypercalcemia in pregnancy due to cyp24a1 mutation
topic Bone & Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624935/
http://dx.doi.org/10.1210/jendso/bvac150.303
work_keys_str_mv AT aguchinyere lbsat130hypercalcemiainpregnancyduetocyp24a1mutation
AT choei lbsat130hypercalcemiainpregnancyduetocyp24a1mutation
AT restachristine lbsat130hypercalcemiainpregnancyduetocyp24a1mutation
AT lubarakhlin lbsat130hypercalcemiainpregnancyduetocyp24a1mutation